|
|
BSE |
NSE |
|
|
Products & Services > Company Profile > Profit & Loss |
|
| GlaxoSmithkline Consumer Healthcare Ltd(Merged) | Industry : Food - Processing - MNC | BSE Code: | 500676 | | NSE Symbol: | GSKCONS | | P/E : | 39.13 | ISIN Demat: | INE264A01014 | | Div & Yield %: | 0.98 | | EPS : | 274.81 | Book Value: | 989.4816928 | | Market Cap (Rs.Cr): | 45229.85 | | Face Value : | 10 | |
|
(Rs. In Crores) |
|
| | | | | | Sales Turnover | 4782.01 | 4377.05 | 4425.91 | 4564.38 | 4531.03 | 5144.49 | Excise Duty | 0.00 | 60.54 | 434.63 | 428.11 | 223.44 | 275.91 | Net Sales | 4782.01 | 4316.51 | 3991.28 | 4136.27 | 4307.59 | 4868.58 | Other Income | 432.60 | 257.41 | 239.06 | 277.51 | 221.89 | 206.91 | Stock Adjustments | 58.92 | -40.98 | 7.66 | 2.70 | 42.97 | -8.91 | Total Income | 5273.53 | 4532.94 | 4238.00 | 4416.48 | 4572.45 | 5066.58 | | | | | | | Raw Materials | 1207.83 | 1136.92 | 1061.20 | 1346.24 | 1542.10 | 1368.78 | Power & Fuel Cost | 76.79 | 73.43 | 72.31 | 78.66 | 65.22 | 98.19 | Employee Cost | 644.62 | 527.73 | 450.86 | 504.98 | 431.29 | 470.05 | Other Manufacturing Expenses | 341.07 | 306.34 | 296.79 | 49.22 | 212.61 | 574.19 | Selling & Administrative Expenses | 1408.43 | 1327.91 | 1092.48 | 1310.84 | 1325.71 | 1305.22 | Miscellaneous Expenses | 21.22 | 19.84 | 186.99 | 10.87 | 43.54 | 170.46 | Less : Pre-operative Expenses Capitalised | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Total Expenditure | 3699.96 | 3392.18 | 3160.63 | 3300.81 | 3620.47 | 3986.89 | Operating Profit | 1573.58 | 1140.76 | 1077.37 | 1115.67 | 951.97 | 1079.67 | Interest | 0.78 | 2.03 | 2.78 | 2.28 | 0.74 | 1.05 | Gross Profit | 1572.80 | 1138.73 | 1074.59 | 1113.39 | 951.23 | 1078.62 | Depreciation | 60.50 | 64.37 | 64.18 | 57.44 | 62.09 | 62.55 | Profit Before Tax | 1512.30 | 1074.36 | 1010.41 | 1055.95 | 889.14 | 1016.07 | Tax | 527.93 | 361.91 | 370.23 | 376.85 | 316.93 | 370.00 | Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Deferred Tax | 1.56 | 12.35 | -16.50 | -8.18 | -11.38 | -28.68 | Reported Net Profit | 982.80 | 700.10 | 656.68 | 687.28 | 583.60 | 674.75 | Extraordinary Items | 0.29 | 0.25 | 0.00 | 0.68 | -5.27 | 0.00 | Adjusted Net Profit | 982.51 | 699.85 | 656.68 | 686.60 | 588.87 | 674.75 | Adjustment below Net Profit | -57.79 | -43.26 | -38.33 | -51.00 | -5.02 | -1.46 | P & L Balance brought forward | 2397.25 | 2034.80 | 1710.84 | 1374.55 | 852.04 | 467.64 | Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Appropriations | 315.42 | 294.39 | 294.39 | 300.00 | 336.75 | 288.89 | P & L Balance carried down | 3006.85 | 2397.25 | 2034.80 | 1710.84 | 1093.86 | 852.04 | Dividend | 441.58 | 315.42 | 294.39 | 294.39 | 231.31 | 189.25 | Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Equity Dividend % | 1050.00 | 750.00 | 700.00 | 700.00 | 550.00 | 450.00 | Dividend Per Share(Rs) | 105.00 | 75.00 | 70.00 | 70.00 | 55.00 | 45.00 | Earnings Per Share-Unit Curr | 233.69 | 166.47 | 156.15 | 163.42 | 127.57 | 122.24 | Earnings Per Share(Adj)-Unit Curr | 233.69 | 166.47 | 156.15 | 163.42 | 127.57 | 122.24 | Book Value-Unit Curr | 973.65 | 828.70 | 742.51 | 665.48 | 502.44 | 431.06 | Book Value(Adj)-Unit Curr | 973.65 | 828.70 | 742.51 | 665.48 | 502.44 | 431.06 |
|
|
|
|
|
|